Cargando…
Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
Biologic treatments have revolutionised the management of psoriasis in recent years; however, data on their safety profile in large populations and long-term effects are being gathered on an ongoing basis. Ustekinumab is a monoclonal antibody that targets interleukin-12/23 used in the treatment of m...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450299/ https://www.ncbi.nlm.nih.gov/pubmed/32908719 http://dx.doi.org/10.1155/2020/8868553 |